New facility will provide cost-effective manufacturing and clinical testing for pharma and contract research organisations ... BDD has opened its new 122m² GMP manufacturing facility at BioCity near ...

MSD has reported outcomes from a Phase III trial of Keytruda (pembrolizumab) for treating head and neck squamous cell ...

US-based pharmaceutical company MSD has reported ... Last month, MSD and BioCity Biopharmaceuticals partnered to assess Keytruda in combination with BC3195 in a global Phase I/II study for ...

Contract research company BDD has opened a 122 square metre manufacturing facility at BioCity near Glasgow ... supporting research and development for small and medium-sized pharmaceutical companies.

The BDD facility will provide cost-effective manufacturing and clinical testing for pharma and contract research organisations of all sizes. Leading contract research company BDD has opened its new ...

Speaking aboard Air Force One, Trump signalled a fresh approach to trade restrictions, stating that pharmaceuticals would be treated separately under the "Liberation Day" tariff plan. This contradicts ...

Nifty Pharma dropped 6% during Friday's session following comments from US President Donald Trump, who indicated that the pharmaceutical sector is being categorized separately and that he would be ...

Indian pharma stocks, including Sun Pharmaceutical Industries, Gland Pharma, Lupin and others traded sharply lower on Wednesday after the US President Donald Trump said he will soon announce a ...

It’s a party for pharma stocks on Dalal Street. The Nifty Pharma Index is up nearly 4% and Sun Pharma, Gland Pharma and IPCA Labs see gains close to 4% each. Even Lupin and Natco Pharma are ...

Trump’s latest trade war measures included a 26 per cent tariff on Indian exports, but the pharmaceutical sector escaped unscathed. With India being a key supplier of generic medicines to the US, the ...